TABLE 2.
Correlations between serum markers and risk factors
| SOURCE | AGES* | AOPP* | FRAP* | PON* | LCAT* | |
|---|---|---|---|---|---|---|
| Age | 0.172 (0.236) | 0.733 (–0.060) | 0.689 (–0.070) | 0.207 (–0.219) | 0.074 (0.306) | |
| Duration of disease | 0.911 (0.022) | 0.915 (0.021) | 0.890 (0.027) | 0.322 (0.191) | 0.023 (0.422) | |
| PASI | 0.399 (0.147) | 0.031 (–0.365) | 0.120 (0.268) | 0.727 (0.061) | 0.314 (0.175) | |
PASI: Psoriasis Area and Severity Index; AGEs: advanced glycation end products; AOPP: advanced oxidation protein products; FRAP: ferritin-reducing ability of plasma; PON: paraoxonase-1; LCAT: lecithin-cholesterol acyltransferase
*P-value and correlation coefficient